000			00408nam a2200133Ia 4500
999			_c146331 _d146331
020			_a9781848440111
020			_a9781847205995
020			_a1848440111 _a1847205992
040			_cCUS
082			_a346.0486 _bHAR/C
100			_aHaracoglou, Irina
245		0	_aCompetition law and patents: a follow-on innovation perspective in the biopharmaceutical industry/ _cIrina Haracoglou
260			_aCheltenham, UK: _bEdward Elgar, _c2008.
300			_a251 p.
505			_aBiopharmaceutical R & D : the increased importance of cumulative innovation and related concerns The patent system as a system of balancing The patent system and some potential safety nets The right to health as an interpretive principle of patent law Unilateral conduct, IPRs and competition law: a systems' interaction The duty to deal under Art. 82 EC The duty to deal as applied to address technology access problems in the biopharmaceutical industry
650			_aPatent laws and legislation
650			_aPharmaceutical biotechnology _xPatents
650			_aPharmaceutical biotechnology _xLaw and legislation
942			_cWB16